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Introduction: To date, there are insufficient data demonstrating the benefits of preclinically administered
Ringer-lactate (RL) for the treatment of hemorrhagic shock following trauma. Recent animal experiments have
shown that lactate tends to have toxic effects in severe hemorrhagic shock. This study aimed to compare the
effects of RL administered in a rat model of severe hemorrhagic shock (mean arterial blood pressure (MAP): 25
to 30 mmHg) and moderate hemorrhagic shock (MAP: 40 to 45 mmHg).
Methods: Four experimental groups of eight male Wistar rats each (moderate shock with Ringer-saline (RS), moderate
shock with RL, severe shock with RS, severe shock with RL) were established. After achieving the specified depth of
shock, animals were maintained under the shock conditions for 60 minutes. Subsequently, reperfusion with RS or RL
was performed for 30 minutes, and the animals were observed for an additional 150 minutes.
Results: All animals with moderate shock that received RL survived the entire study period, while six animals with
moderate shock that received RS died before the end of the experiment. Furthermore, animals with moderate shock
that received RL exhibited considerable improvements in their acid-base parameters and reduced organ damage.
In contrast, in animals with severe shock, only two of the animals receiving RS survived but all of the animals receiving
RL died early, before the end of the study period. Moreover, the severe shock animals that were treated with RL
exhibited considerably worsened acid-base and metabolic parameters.
Conclusions: The preclinical use of RL for volume replacement has different effects depending on the severity of
hemorrhagic shock. RL exhibits detrimental effects in cases of severe shock, whereas it has pronounced protective
effects in cases of moderate shock.Introduction
Accidents remain a major cause of death. Apart from
severe traumatic brain injury, uncontrolled bleeding
and corresponding hemorrhagic shock play significant
roles in mortality [1-3]. Except for patient positioning
(for example, 30° semi-recumbent position), little preclinical
management of severe craniocerebral trauma is possible;
this condition is the most common cause of premature
mortality. In contrast, hemorrhagic shock can be managed
to prevent fatality. Hess et al. demonstrated that bleeding* Correspondence: bjoern.hussmann@uk-essen.de
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reproduction in any medium, provided the orin hemorrhagic shock and its resulting consequences are
the most common preclinical avoidable cause of death [4].
The sequelae of hemorrhagic shock that generally occur
later after injury, while patients are still in the hospital, such
as single- or multi-organ failure, are the most important
factors in death after severe trauma with bleeding [1].
In addition to the top priority defined by the Advanced
Trauma LifeSupport (ATLS®), that is, to “stop the bleeding”,
volume replacement is typically performed during the
preclinical course of hemorrhagic shock treatment by
administering crystalloid solutions to maintain micro-
circulation [5-8].
Many studies, and in particular, animal experiments, have
shown that resuscitation with lactate-containing solutionstral Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and survival compared to resuscitation using crystalloid
solutions without metabolizable anions [9-11]. However,
lactate-containing solutions may alter plasma lactate
concentrations, which are used as a marker of hypoxemia,
and solutions containing both L-lactate and D-lactate may
induce pulmonary and hepatic apoptosis [12-15].
Contrary to recently published results, our group has
shown that Ringer-lactate (RL) may mediate toxic effects
in rats with severe hemorrhagic shock (mean arterial
blood pressure (MAP) 25 to 30 mmHg) [16]. However,
whether this effect occurs exclusively in severe hemor-
rhagic shock remains unclear. In severe hemorrhagic
shock, energy production is based mainly on anaerobic
metabolism, during which lactate may accumulate.
Therefore, the objective of this study was to investigate
the effects of reperfusion with RL on survival, organ
damage, hemodynamics and acid-base balance in rats
experiencing two different levels of hemorrhagic shock
(MAP 25 to 30 mmHg and 40 to 45 mmHg).
The composition of Ringer-saline (RS) is highly compar-
able with that of Ringer-lactate (RL) except for chloride,
which replaces the metabolizable anion lactate. Due to this
similarity, RS seems to be the appropriate solution to
study the effects of lactate. Although RS is rarely used
clinically, in addition to sodium and chloride, it contains
potassium and calcium ions, thus appearing to be the
more physiological solution, which is another reason for
the use of RS instead of, for example, normal saline as a
control in this study (Table 1).
Materials and methods
Chemicals/materials
RS and RL were obtained from Fresenius (Bad Homburg,
Germany), ketamine 10% was obtained from Ceva
(Düsseldorf, Germany), lidocaine (Xylocaine 1%) was
obtained from AstraZeneca (Wedel, Germany), acidTable 1 Composition of Ringer-saline (RS) and
Ringer-lactate (RL)
RS LR
NaCl 8.6 g/l 6.00 g/l
Na-Lac — 0.34 g/l
KCl 0.30 g/l 0.42 g/l
CaCl2 0.33 g/l 0.27 g/l
Na+ 147.2 mM 131 mM
Cl- 155.7 mM 112 mM
K+ 4 mM 5.6 mM
Ca2+ 2.25 mM 1.84 mM
Lac — 28.3 mM
Osmolarity 309 mOsm/l 278 mOsm/l
Lac, lactate; Na-Lac, sodium lactate.citrate dextrose-A (ACD-A) solution was obtained from
Baxter (Deerfield, IL, USA) and Portex catheters (inner
diameter: 0.58 mm, outer diameter: 0.96 mm) were
obtained from Smiths Medical International (Hythe, UK).
Animals
Male Wistar rats (400 to 450 g) were obtained from the
central animal unit of the Essen University Hospital.
Animals were kept under standardized temperature
(22 ± 1°C) and humidity (55 ± 5%) conditions with a
12-h:12-h light:dark cycle. Animals were fed ad libitum
(ssniff-Spezialdiäten, Soest, Germany) with free access to
water and were not fasted prior to the experiments. All
animals received ethical care according to the standards
of Annex III of directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010
on the protection of animals used for scientific purposes
[17]. The experimental protocol was approved by the North
Rhine-Westfalia State Office for Nature, Environment,
and Consumer Protection (Landesamt für Natur, Umwelt,
und Verbraucherschutz Nordrhein Westfalen), Germany,
based on the local animal protection act.
Anesthesia, analgesia and surgical procedures
The resuscitation schedule and anesthesia, analgesia,
catheter insertions, shock induction, blood sampling and
organ resection were performed as described previously
[18], with minor modifications. Rats were anesthetized
with isoflurane (2% in 100% medical O2 at 4 l/minute for
anesthesia induction; 1% to 1.5% at 1 l/minute throughout
the experiment) using face masks connected to a vaporizer
(Isoflurane Vet. med. Vapor; Dräger, Lübeck, Germany)
and received ketamine (50 mg/kg, subcutaneously (s.c.))
administered into the right chest wall for analgesia.
Lidocaine (5 mg/kg, s.c.) was administered into the right
groin before a skin-deep incision was made for catheter
insertion. Subsequently, a Portex catheter was placed into
the femoral artery, and an identical catheter was placed
into the femoral vein. Each catheter was held in place with
surgical sutures.
Induction of hemorrhagic shock and resuscitation regimen
The animals were allowed to adapt to the catheter inser-
tion before hemorrhagic shock induction. Shock was
induced by removing 2 ml blood every three minutes
through the femoral artery catheter using a 2-ml syringe
(Terumo, Leuven, Belgium). The first syringe was prefilled
with 0.2 ml acid citrate dextrose-A solution (ACD-A). The
syringe with citrated blood was stored at 37°C and used to
adjust shock severity, if needed. Bleeding was continued
until the MAP dropped to 1) 25 to 30 mmHg (severe
shock) or 2) 40 to 45 mmHg (moderate shock); this
process typically required approximately 20 minutes.
Because all animals exhibited a similar weight (400 to
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weight in this range, the shed blood volume in the
groups to be compared was nearly identical. The blood
volume withdrawn in the severe shock groups was
about 12 to 14 ml, whereas it was around 6 to 8 ml in
the moderate shock groups. For the next 60 minutes,
the MAP was maintained, typically without requiring
further intervention. In some cases, however, small
amounts (0.1 to 0.5 ml aliquots) of the citrated blood
were administered, or additional blood (0.1 to 0.5 ml
aliquots) was withdrawn to maintain the MAP within
the desired range. After the shock phase, study group-
specific resuscitation fluids were infused via the femoral
vein using a syringe pump (Perfusor-Secura FT; B Braun,
Melsungen, Germany), requiring approximately 30 minutes.
Experiments were continued for another 150 minutes or
until the rat died. To compensate for fluid loss via surgical
areas and the respiratory epithelium, 0.9% NaCl solution
(5 ml/kg × h, 37°C) was infused through the femoral vein
catheter throughout the entire experiment [18].
Experimental groups
All 38 animals were randomly assigned to the following
groups:
– sham group (no shock, no resuscitation, six animals)
– moderate shock/RS group (40 to 45 mmHg MAP,
resuscitation with RS equivalent to three times the
shed blood volume, eight animals)
– moderate shock/RL (40 to 45 mmHg MAP,
resuscitation with RL equivalent to three times the
shed blood volume, eight animals)
– severe shock/RS group (25 to 30 mmHg MAP,
resuscitation with RS equivalent to three times the
shed blood volume, eight animals)
– severe shock/RL group (25 to 30 mmHg MAP,
resuscitation with RL equivalent to three times the
shed blood volume, eight animals)
The fluid volume used for resuscitation was based on
the well-known 3:1 rule [19].
Biomonitoring
Systolic blood pressure, diastolic blood pressure and MAP
were recorded continuously via the femoral artery catheter,
which was connected to a pressure transducer, and dis-
played on a monitor. RS was delivered at a rate of 3 ml/
h to maintain catheter functionality. The heart rate was
determined using systolic blood pressure spikes. The core
body temperature was continuously monitored using a
rectal probe. Cooling was prevented with the use of a
heated operating table and by covering the animals with
aluminum foil. Oxygen saturation was recorded continu-
ously using a pulse oximeter (OxiCliq A; Nellcor, Boulder,CO, USA) placed at the left hind limb. The breathing rate
was determined in 10-minute intervals based on the
number of ventilation movements within 15 sec.
Assessment of blood and plasma parameters
A 2-ml syringe containing 80 IU electrolyte-balanced hep-
arin (Pico50; Radiometer Medical, Brønshøj, Denmark) was
used to collect blood samples (0.7 ml) from the femoral
artery catheter for blood gas analysis and for the assessment
of marker enzyme activities. Blood was collected immedi-
ately after syringe insertion (T = 0 minute), after the inser-
tion of all catheters (T = 10 minutes), at the end of shock
induction (T = 40 minutes), immediately before initiating
resuscitation (T = 100 minutes), at the end of resuscitation
(T = 130 minutes), and during the final observation phase
(T = 160 minutes, 220 minutes and 280 minutes). After
each blood sample was drawn, the animal was given a
0.7 ml bolus of RS via the femoral artery (with the add-
itional effect of flushing the catheter and maintaining
its functionality). Arterial blood pH, oxygen and carbon
dioxide partial pressures (pO2, pCO2); oxygen saturation;
base excess (BE); hemoglobin concentration; hematocrit;
electrolytes (Na+, K+, Cl-, Ca2+); metabolic parameters
(lactate and glucose concentrations); and osmolality were
assessed using a blood gas analyzer (ABL 715; Radiometer,
Copenhagen, Denmark). Blood plasma was obtained by
centrifugation at 3,000 × g for 15 minutes at 25°C, stored
at 4°C, and used within 4 h. The plasma activity of lactate
dehydrogenase (LDH), as a general marker for cell injury;
aspartate aminotransferase (AST) and alanine amino-
transferase (ALT), as markers for liver cell injury; creat-
ine kinase (CK), as a marker for muscle cell injury; and
plasma creatinine concentration, as a marker of renal
function, were determined with a fully automated clinical
chemistry analyzer (Vitalab Selectra E®; VWR International,
Darmstadt, Germany).
Statistics
Experiments were performed with eight animals per experi-
mental group, except for the sham group, which consisted
of six animals. Data are expressed as the mean values ±
SEM. Outliers were removed after box-plot analysis. Mul-
tiple group comparisons of the post-resuscitation phase
were performed using one-way analysis of variance
(ANOVA) for independent or repeated measures. ANOVAs
were followed by Fisher’s Least Significant Difference (LSD)
post-hoc analysis. Survival curves were generated according
to the Kaplan-Meier method and were compared with the
log rank test. P-values <0.05 were considered significant.
Results
Survival
All animals of the sham group survived (not shown).
The same was true for all animals of the moderate shock/
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the moderate shock/RS group survived the entire study
period. The earliest death in this group occurred at 110
minutes after resuscitation, that is, at T = 240 minutes
of the overall experimental time.
The earliest death in the severe shock/RS group occurred
80 minutes after resuscitation, but two animals survived
the entire study period. All rats in the severe shock/RL
group died within 110 minutes after resuscitation. The
earliest death in this group occurred 50 minutes after
resuscitation, that is, at T = 180 minutes.
Hemodynamics and other systemic parameters
In the sham group, the MAP remained at approximately
105 mmHg (Figure 2A). In the moderate shock groups, the
MAP was lowered to 40 to 45 mmHg within 20 minutes
of shock induction and maintained in this range for 60
minutes. Upon resuscitation, the MAP returned to an
average level of 110 mmHg in the animals of both
moderate shock groups. Following resuscitation, the
MAP of the moderate shock/RS group continuously
decreased to approximately 35 mmHg at the end of
the experiment. In the moderate shock/RL group, the
MAP only slightly decreased after resuscitation and
remained at approximately 70 mmHg for the remainder
of the experiment.
In the severe shock groups, the MAP was reduced to
25 to 30 mmHg within 20 minutes of shock induction
and maintained at this level for 60 minutes (Figure 2A).Figure 1 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
survival after shock. Rats were subjected to moderate or severe
hemorrhage, resuscitated with either Ringer-saline (RS) or Ringer-lactate
(RL), and then observed until all animals of the shock/RS and the
shock/RL group died (between T = 50 and T = 150 minutes). The
survival of each group is shown as a Kaplan-Meier plot (n = 8, logrank
*P <0.05; vs. severe shock/RL, # P <0.05 vs. severe and moderate
shock/RS groups).
Figure 2 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
blood pressure and heart rate after shock. Rats were subjected
to moderate or severe hemorrhage (shock induction: dark gray;
shock phase: light gray), resuscitated (dark gray) with either
Ringer-saline (RS) or Ringer-lactate (RL), and observed until the end
of the experiment or until the first animal of each comparison group
died. (A) Mean arterial blood pressure (MAP) and (B) heart rate
(HR; bpm, beats per minute). The results are shown as the mean
values ± SEM (n = 8 animals per shock group, n = 6 sham group
animals). SEM values that are not visible are located behind the
symbols. One-way repeated-measures ANOVA with Fisher’s Least
Significant Difference (LSD) post-hoc test were performed with
* P <0.05 (vs. all other shock groups); # P <0.05 (vs. severe
shock groups).Upon resuscitation, the MAP recovered to approximately
75 mmHg (in the severe shock/RS group) and 65 mmHg
(in the severe shock/RL group). In the post-resuscita-
tion phase, the MAP rapidly dropped to approximately
30 mmHg and remained at this level until the death of
the animals.
The heart rates of the animals in the sham group
remained stable at approximately 270 beats per minute
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decreased to approximately 180 bpm during shock in-
duction and recovered progressively during the shock
period and the resuscitation phase. In the moderate
shock/RS and moderate shock/RL groups, the heart rates
increased to 250 bpm and remained at this level in the
post-resuscitation phase. In the severe shock/RS and
severe shock/RL groups, heart rates of approximately
300 bpm were observed in the post-resuscitation phase.
The mean breathing rate of the sham group animals
was approximately 50 breaths per minute (data not shown).
In all animals of the shock groups, the respiratory rate
was approximately 60 breaths per minute during shock
induction, the shock period and the post-resuscitation
phase (data not shown).
The core body temperature of the sham group animals
remained at approximately 37°C throughout the experi-
ment (data not shown). In contrast, the temperature of
all shock group animals decreased by almost 1°C during
shock induction and in the shock phase and returned to
37°C upon resuscitation.
Plasma electrolyte concentration
Plasma Na+, Ca2+ and K+ concentrations remained almost
constant in all groups (Table 2). The plasma Cl- concen-
trations of both shock groups that received RS were
significantly greater than those of the sham control and
the RL-receiving groups.
Acid-base and metabolic status
In the sham group, the blood pH, base excess and pCO2
values remained almost constant at 7.3, -2 mmol/l and
55 mmHg, respectively (Figure 3A-C). In the severe
shock and moderate shock groups, metabolic acidosis
was observed, as indicated by reduced pH and/or base
excess, which was partially compensated by a decrease
(normalization) in pCO2. Metabolic acidosis was most
pronounced at the end of the shock phase and recovered
partially, but only temporarily, upon resuscitation andTable 2 Effects of Ringer-saline (RS) and Ringer-lactate (RL) o
Sham Sham Severe shock/RS
Parameter T = 20 minutes T = 280 minutes T = 170 minutes
Hematocrit (%) 40.2 ± 0.24 32.01 ± 0.86 21.2 ± 0.7
Na+ (mmol/l) 138.8 ± 0.3 138.5 ± 0.5 141.1 ± 0.8
Ca2+ (mmol/l) 1.4 ± 0.01 1.4 ± 0.02 1.5 ± 0.03
K+ (mmol/l) 5.1 ± 0.05 5.5 ± 0.2 5.6 ± 0.1
Cl- (mmol/l) 105 ± 0.6 111 ± 0.9 121 ± 0.6
Rats were subjected to moderate or severe hemorrhage and then resuscitated with
concentrations were measured before shock induction (baseline, T = 10 minutes), at
or at T = 150 minutes (that is, the last blood sample taken before the earliest death
the sham group were not significantly different from those of the other groups. Val
# P <0.05 (vs. severe shock/RS).during the post-resuscitation phase. The most acidic pH
(below 7.2) and the lowest base excess values (−15 mmol/l)
were observed in animals of the severe shock groups,
with minor differences between the severe shock/RS
and severe shock/RL group. In the moderate shock/RS
group, metabolic acidosis remained pronounced (base
excess −11 mmol/l at the end of the shock phase), while
in the moderate shock/RL group only slight metabolic
acidosis with almost normal pH values was observed.
The pO2 varied between 350 and 490 mmHg with no
significant differences within or among the study groups
(Figure 3D).
The blood lactate concentration remained below
1.5 mmol/l in the sham group (Figure 4A). Consistent
with the results indicating shock-induced metabolic
acidosis, blood lactate rapidly increased to approximately
4 mM after shock induction. In the moderate shock
groups, the blood lactate concentrations remained at
this level during the shock phase, whereas those of the
severe shock groups increased further, to 7 mmol/l. Upon
resuscitation, the blood lactate concentrations promptly
decreased to 1 mmol/l in both moderate shock groups
and to 2.5 and 4 mmol/l in the severe shock/RS and severe
shock/RL groups, respectively. Lactate levels remained
roughly constant (in the severe shock groups) or increased
slightly (in the moderate shock groups) until the animals
died (or until the end of the experiment).
In the sham group, the blood glucose concentration
was approximately 170 mg/dl (Figure 4B). In the shock
groups, the blood glucose levels increased to 240 to
270 mg/dl (in moderate shock) and 300 mg/dl (in severe
shock) after shock induction. However, the glucose levels
decreased to approximately 200 mg/dl during the shock
phase. Decreases in blood glucose continued upon resusci-
tation, resulting in levels of approximately 100 mg/dl.
While the blood glucose concentration remained constant
at this level in the moderate shock/RL group, it further
decreased, to approximately 50 mg/dl, just prior to death
in the moderate shock/RS group; a similar but more rapidn hematocrit and plasma electrolytes after shock
Severe shock/RL Moderate shock/RS Moderate shock/RL
T = 170 minutes T = 230 minutes T = 230 minutes
21.3 ± 0.7 23.3 ± 1.2 23.8 ± 1.0
138.3 ± 0.9 140.7 ± 1.2 138.8 ± 0.8
1.5 ± 0.02 1.4 ± 0.04 1.4 ± 0.03
5.6 ± 0.2 5.9 ± 0.3 5.6 ± 0.2
117 ± 0.9*# 122 ± 2.3 116 ± 1.5*#
either Ringer-saline (RS) or Ringer-lactate (RL). Electrolyte and hematocrit
the end of the experiment (sham group; shock/RS, shock/RL; T = 280 minutes)
in the groups to be compared, shock/RS and shock/RL). The baseline values of
ues are shown as the means ± SEM. *P <0.05 (vs. moderate shock/RS);
Figure 3 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on the acid–base equilibrium and pO2 after shock. Rats were subjected to
moderate or severe hemorrhage (shock induction: dark gray; shock phase: light gray), resuscitated (dark gray) with either Ringer-saline (RS) or
Ringer-lactate (RL), and observed until the end of the experiment or until the first of the animals of the comparison groups died. Blood gas
analysis was performed at distinct time intervals, with T = 280 minutes representing the last possible point of comparison. The following
parameters were determined in arterial blood samples at the indicated time points: (A) blood pH, (B) base excess, (C) CO2 partial pressure
(pCO2) and (D) O2 partial pressure (pO2). Values are presented as the means ± SEM (n = 8 animals per shock group, n = 6 sham group animals).
SEM values that are not visible are located behind the symbols. *P <0.05 (vs. all other shock groups), # P <0.05 (vs. severe shock/RS group).
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severe shock groups.
Parameters of organ injury
The blood plasma LDH and CK activity in the sham group
animals remained below 350 U/l and 200 U/l, respectively
(Figure 5A,B), and the plasma AST and ALT activities
remained constant at 70 U/l and 60 U/l, respectively
(Figure 6A,B). In the shock groups, all plasma enzyme
activity remained at similar values during shock induction
and increased only slightly, if at all, during the shock
phase. Upon resuscitation and in the post-resuscitation
phase, however, the plasma enzyme activities of LDH, CK,
AST and ALT increased several fold. These increases were
more pronounced in the severe shock animals than in
the moderate shock animals. In the moderate shock/RL
group; however, the increases in enzyme activities were
significantly less than in the other shock groups, for
example, the increase in LDH activity in the moderate
shock/RL group was significantly less than the increase
in the moderate shock/RS group (800 vs. 1,500 U/l at
T = 240 minutes; Figure 5A).Plasma creatinine concentrations remained stable at
approximately 0.7 mg/dl in the sham group (Figure 7).
During shock induction and the shock phase, plasma
creatinine rose to 1 mg/dl. Upon resuscitation, plasma
creatinine decreased slightly to 0.8 mg/dl and rose again
after resuscitation in both severe shock groups and the
moderate shock/RS group. In the moderate shock/RL
group, however, plasma creatinine remained constant
at 0.8 mg/l during the entire post-resuscitation phase
and was thus significantly lower than the creatinine
levels observed in the moderate shock/RS group.
Discussion
Under physiological conditions, lactate is mainly produced
in the skin, muscles, erythrocytes, brain and intestinal mu-
cosa [20]. These tissues produce approximately 1,300 mmol
of lactate per day. It has been reported that plasma lactate
concentration may vary depending on the physiological
status of the body, but to a similar extent in different
species [21-23]. Up to 60% of intrinsic lactate is metab-
olized by the liver [20], where it is either converted
back to glucose (gluconeogenesis) or degraded to CO2
Figure 4 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
blood lactate and glucose concentration after shock. Rats were
subjected to moderate or severe hemorrhage (shock induction: dark
gray; shock phase: light gray), resuscitated (dark gray) with either
Ringer-saline (RS) or Ringer-lactate (RL), and observed until the end
of the experiment or until the first of the animals of the comparison
groups died. Blood gas analysis was performed at distinct time
points, with T = 280 minutes representing the last possible point of
comparison. Blood lactate (A) and glucose concentrations (B) were
measured at the indicated time points. Values are presented as the
means ± SEM (n = 8 animals per shock group, n = 6 sham group
animals). SEM values that are not visible are located behind the
symbols. One-way repeated-measures ANOVA and Fisher’s Least
Significant Difference (LSD) post-hoc test were performed. # P <0.05
(vs. severe shock groups); ‡ P <0.05 (vs. moderate shock/RS group).
Figure 5 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
lactate dehydrogenase and creatine kinase activity after shock.
Rats were subjected to moderate or severe hemorrhage (shock
induction: dark gray; shock phase: light gray), resuscitated (dark gray)
with either Ringer-saline (RS) or Ringer-lactate (RL), and observed
until the end of the experiment or until the first of the animals of
the comparison groups died. Blood gas analysis was performed at
distinct time points, with T = 280 minutes representing the last
possible point of comparison. Lactate dehydrogenase (LDH) activity
(A) and creatine kinase (CK) activity (B) were determined at the
indicated time points. The values are presented as the means ± SEM
(n = 8 animals per shock group, n = 6 sham group animals). SEM
values that are not visible are located behind the symbols. One-way
repeated-measures ANOVA and Fisher’s Least Significant Difference
(LSD) post-hoc test were performed. # P <0.05 (vs. severe shock/RS
group), ‡ P <0.05 (vs. moderate shock/RS group).
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O2 to be supplied to the liver; one H
+ ion is consumed
(alternative view: one HCO3
– is generated) per lactate
molecule that is metabolized. Therefore, lactate is involved
in maintaining the acid-base equilibrium under aerobic
conditions. Hartmann first added lactate to RS to compen-
sate for metabolic acidosis [24]. The alkalization thataccompanies lactate metabolism was later confirmed
by several other research groups [9,10,25,26]. In direct
contrast, a recently published paper [16] and the present
experiments report that neither an alkalizing effect of
lactate infusion, that is, an improvement of metabolic
acidosis, nor an improvement of organ injury or survival
was observed in resuscitation with RL compared to resus-
citation with RS in severe hemorrhagic shock. Actually,
Figure 6 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
liver damage parameters after shock. Rats were subjected to
moderate or severe hemorrhage (shock induction: dark gray; shock
phase: light gray) and then resuscitated (dark gray) with either
Ringer-saline (RS) or Ringer-lactate (RL). Blood AST and ALT
concentrations (A, B) were measured continuously throughout the
experiment and recorded at the indicated time points until either
the end of the experiment or the first of the animals of the
comparison groups died. Blood gas analysis was performed at specific
time points, with T = 280 minutes representing the last possible point
of comparison. Values are presented as the means ± SEM (n = 8 animals
per shock group, n = 6 sham group animals). SEM values that are not
visible are located behind the symbols. One-way repeated-measures
ANOVA and Fisher’s Least Significant Difference (LSD) post-hoc test
were performed. * P <0.05 (vs. severe shock/RS group).
Figure 7 Effects of Ringer-saline (RS) and Ringer-lactate (RL) on
kidney injury parameters after shock. Rats were subjected to
moderate or severe hemorrhage (shock induction: dark gray; shock
phase: light gray) and then resuscitated (dark gray) with Ringer-saline
(RS) or Ringer-lactate (RL). Blood creatinine concentration was measured
continuously throughout the experiment and recorded at the time
points indicated until the end of the experiment or until the first
of the animals of the comparison groups died. Blood gas analysis was
performed at distinct time points, with T = 280 minutes representing
the last possible point of comparison. Values are presented as the
means ± SEM (n = 8 animals per shock group, n = 6 sham group
animals). SEM values that are not visible are located behind the
symbols. One-way repeated-measures ANOVA and Fisher’s Least
Significant Difference (LSD) post-hoc test were performed. * P <0.05
(vs. all other shock groups).
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fluid in severe shock. The lack of an effect of lactate
on acid-base status most likely resulted from impaired
lactate metabolism, even in the resuscitation and post-
resuscitation phases. It is likely that following severe shock,
distinct areas of the reperfused organs, particularly of the
liver, are injured or remain anoxic despite resuscitation
and are thus incapable of metabolizing lactate to glucoseand/or CO2 and H2O [27]. Impaired liver function was
also suggested by the dramatic drop in blood glucose
concentrations that was observed in all of the shock
groups. The deleterious effects of lactate infusion on
survival, however, cannot solely be explained by impaired
lactate metabolism in severe hemorrhagic shock. The
inhibition of glycolysis by the high concentrations of
lactate that accumulate under these conditions [28-30]
is likely also required for these adverse effects. In line
with this assumption, the lactate concentration upon
resuscitation and in the post-resuscitation phase was clearly
elevated in the RL group animals; although not significantly
as compared with the severe shock/RS group animals.
However, in moderate hemorrhagic shock, resuscitation
with RL improved metabolic acidosis and enhanced
survival. Improved acid-base status is expected given
the considerations given above; that is, following moderate
hemorrhagic shock, lactate appears to be metabolized
at a rate that is sufficiently high to consume significant
amounts of H+ and improve the acid-base balance. More-
over, in the moderate shock, lactate appears to ameliorate
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blood glucose concentrations in the post-resuscitation
phase, whereas in the animals resuscitated with RS blood
glucose concentration dropped to a minimum. Both effects
are likely to contribute decisively to the prolonged initial
survival observed in the moderate shock/RL animals.
Lactate infusion-related protection following moderate
hemorrhagic shock is congruent with the results that
have been reported by other groups in dog or swine
models of moderate hemorrhagic shock [6,11].
Numerous publications and the current S3 guideline
of the German Society for Trauma Surgery (Deutsche
Gesellschaft für Unfallchirurgie) indicate lactated RL over
normal saline (NS) for preclinical therapy in polytrauma
patients with hemorrhagic shock thereby neglecting the
potential adverse effects of RL [10,31,32]. However, the
current guidelines do not differentiate between moderate
and severe forms of hemorrhagic shock; the vast majority
of trauma patients with hemorrhagic shock experience
mainly moderate shock. Considering the present results,
which suggest that RL is more beneficial than NS in
moderate hemorrhagic shock, the general recommendation
to prefer RL to NS as a resuscitation fluid appears to be
justified. On the other hand, a more sophisticated recom-
mendation to treat moderate hemorrhagic shock with RL
but treat severe hemorrhagic shock with pure crystalloids,
that is, non-lactated crystalloid solutions, may further
improve therapeutic success. Such an approach, however,
is challenging to study due to the relatively small number
of patients who experience severe hemorrhagic shock
and the high risk of death at the scene.
Finally, some limitations to the present study exist.
The isoflurane used in the experimental model mediates
vasodilation, which may maintain blood flow to vital organs
but may also decrease MAP and heart rate due to vasodila-
tory effects [33]. However, this applies to all of the groups
studied in the present experiment, and analgesia must be
used for ethical reasons. More importantly, the present
study uses an animal model, which cannot reflect the
full scope of preclinical emergency situations. For example,
it was not possible to establish preclinical permissive
hypotension, which is commonly desirable, because this
study focused on comparing the effects of the substances
administered on different types of shock.
Conclusions
The present study clearly demonstrates that RL is toxic
in the resuscitation of severe hemorrhagic shock but
protective in the treatment of moderate hemorrhagic
shock with respect to initial survival, acid-base parameters
and organ damage. However, further experimental studies
are necessary to determine whether other metabolizable
anions, such as acetate or malate, behave similarly to
lactate and to elucidate the effects of lactate inpermissive hypotension observed in real-life emergency
situations.
Key messages
 Ringer-lactate may mediate toxic effects in rats with
severe hemorrhagic shock (mean arterial blood
pressure 25 to 30 mmHg).
 Ringer-lactate is protective in the treatment of
moderate hemorrhagic shock (mean arterial
blood pressure 40 to 45 mmHg) with respect to
initial survival.
 In moderate hemorrhagic shock, resuscitation with
Ringer-lactate improved metabolic acidosis and
decreased organ injury.
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